Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Piris

Showing results (151-160 of 231) with videos related to

Pageof 24
Sort By:
Cancers|July 2, 2021
Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue LymphomaBarbara Kiesewetter, Christiane Copie-Bergman, Michael Levy, et al.
Oncotarget|September 2, 2015
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesSoraya Curiel-Olmo, Almudena García-Castaño, Rebeca Vidal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study GroupCarlos Montalbán, Juan F García, Víctor Abraira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samplesBeatriz Sánchez-Espiridión, Abel Sánchez-Aguilera, Carlos Montalbán, et al.
British Journal of Haematology|March 17, 2010
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphomaAndrea Rinaldi, Daniela Capello, Marta Scandurra, et al.
Haematologica|June 9, 2018
<i>In vitro</i> and <i>in vivo</i> activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphomaMontserrat Pérez-Salvia, Eneko Aldaba, Yosu Vara, et al.
British Journal of Haematology|March 23, 2011
Integrated profiling of diffuse large B-cell lymphoma with 7q gainEkaterina Chigrinova, Michael Mian, Yulei Shen, et al.
British Journal of Haematology|June 4, 2013
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphomaBeatriz Sánchez-Espiridión, Ana M Martín-Moreno, Carlos Montalbán, et al.
British Journal of Cancer|September 27, 2017
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocationsCarlo Visco, Jinfen Wang, Maria Chiara Tisi, et al.
Blood|March 23, 2006
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphomaAbel Sánchez-Aguilera, Carlos Montalbán, Paloma de la Cueva, et al.
Pageof 24

Showing results (151-160 of 231) with videos related to

Sort By:
Pageof 24
Cancers|July 2, 2021
Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue LymphomaBarbara Kiesewetter, Christiane Copie-Bergman, Michael Levy, et al.
Oncotarget|September 2, 2015
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesSoraya Curiel-Olmo, Almudena García-Castaño, Rebeca Vidal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study GroupCarlos Montalbán, Juan F García, Víctor Abraira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samplesBeatriz Sánchez-Espiridión, Abel Sánchez-Aguilera, Carlos Montalbán, et al.
British Journal of Haematology|March 17, 2010
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphomaAndrea Rinaldi, Daniela Capello, Marta Scandurra, et al.
Haematologica|June 9, 2018
<i>In vitro</i> and <i>in vivo</i> activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphomaMontserrat Pérez-Salvia, Eneko Aldaba, Yosu Vara, et al.
British Journal of Haematology|March 23, 2011
Integrated profiling of diffuse large B-cell lymphoma with 7q gainEkaterina Chigrinova, Michael Mian, Yulei Shen, et al.
British Journal of Haematology|June 4, 2013
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphomaBeatriz Sánchez-Espiridión, Ana M Martín-Moreno, Carlos Montalbán, et al.
British Journal of Cancer|September 27, 2017
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocationsCarlo Visco, Jinfen Wang, Maria Chiara Tisi, et al.
Blood|March 23, 2006
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphomaAbel Sánchez-Aguilera, Carlos Montalbán, Paloma de la Cueva, et al.
Pageof 24